Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 90-0648733 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To support research and clinical trials that will cure neurobastoma with an emphasis on non-toxic treatments.
Principal Officer
FRANK Kalman
Total Revenue
$73K
FY2024
Total Expenses
$44K
FY2024
Net Assets
$62K
Program Ratio
100.0%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.